Literature DB >> 10931142

Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

T K Kondratieva1, N V Kobets, S V Khaidukov, V V Yeremeev, I V Lyadova, A S Apt, M F Tam, M M Stevenson.   

Abstract

Pseudomonas aeruginosa-resistant BALB/c and susceptible C57Bl/6 (B6) mice were immunized with heat-killed Pseudomonas either in the foot pad or via the trachea, and panels of Pseudomonas-specific T cell clones were developed from lymph nodes and lungs. All clones from either strain, whether of lymph node or lung origin, were CD3+CD4+CD8-TCRalphabeta+. The efficacy of cloning from lymph node cells was comparable between BALB/c and B6 mice. All lymph node BALB/c clones proliferated in response to Pseudomonas antigen in a dose-dependent manner, and this response was MHC class II-restricted. Vigorous proliferation by a considerable proportion of B6 T cell clones occurred in the absence of specific antigen. Lymph node clones from either strain could be categorized as either Th1 or Th0 on the basis of interferon-gamma (IFN-gamma)/IL-4 production. In either mouse strain the efficacy of cloning from lung tissue was substantially lower than from lymph nodes, but the efficacy of cloning from BALB/c compared with B6 lungs was higher. Four lung T cell clones from BALB/c and two from B6 mice were expanded for further analyses, and an interstrain difference was observed in cytokine production. Both B6 lung T cell clones were Th1-like and produced IFN-gamma but not IL-4 and IL-10, whereas four BALB/c lung T cell clones were Th2-like and produced IL-4 and IL-10 but not IFN-gamma. These observations suggest that differences in the CD4+ Th response in the lung may contribute to differences among inbred mouse strains in the level of resistance to bronchopulmonary Pseudomonas infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931142      PMCID: PMC1905701          DOI: 10.1046/j.1365-2249.2000.01222.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Extraction of immune and inflammatory cells from human lung parenchyma: evaluation of an enzymatic digestion procedure.

Authors:  P G Holt; B W Robinson; M Reid; U R Kees; A Warton; V H Dawson; A Rose; M Schon-Hegrad; J M Papadimitriou
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

2.  T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.

Authors:  W G Powderly; G B Pier; R B Markham
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Decreased T helper cell function in patients with cystic fibrosis.

Authors:  A P Knutsen; R G Slavin; S T Roodman; K R Mueller; N L Marino
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

4.  Study of helper and suppressor T-cells in cystic fibrosis.

Authors:  R Van Geffel; E Hubert; J Urbain
Journal:  Immunol Lett       Date:  1982-09       Impact factor: 3.685

5.  Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

6.  Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.

Authors:  S Chouaib; K Welte; R Mertelsmann; B Dupont
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

7.  Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.

Authors:  G B Pier; R B Markham
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

8.  Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  In vitro response of human T cells to Pseudomonas aeruginosa.

Authors:  J M Porwoll; H M Gebel; G E Rodey; R B Markham
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Identification of the principal T lymphocyte-stimulating antigens of Pseudomonas aeruginosa.

Authors:  M J Parmely; B H Iglewski; R T Horvat
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  11 in total

1.  IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.

Authors:  Gregory P Priebe; Rebecca L Walsh; Terra A Cederroth; Akinobu Kamei; Yamara S Coutinho-Sledge; Joanna B Goldberg; Gerald B Pier
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.

Authors:  Gregory P Priebe; Mary M Brinig; Kazue Hatano; Martha Grout; Fadie T Coleman; Gerald B Pier; Joanna B Goldberg
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.

Authors:  Gregory P Priebe; Gloria J Meluleni; Fadie T Coleman; Joanna B Goldberg; Gerald B Pier
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

4.  Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  Adam J Ritchie; Andrew O W Yam; Kara M Tanabe; Scott A Rice; Margaret A Cooley
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

5.  An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis.

Authors:  I Lyadova; V Yeremeev; K Majorov; B Nikonenko; S Khaidukov; T Kondratieva; N Kobets; A Apt
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

6.  Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa.

Authors:  Christine Tertilt; Ju Joh; Anja Krause; Paigee Chou; Kristin Schneeweiss; Ronald G Crystal; Stefan Worgall
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

7.  Ubiquitination by SAG regulates macrophage survival/death and immune response during infection.

Authors:  S C Chang; J L Ding
Journal:  Cell Death Differ       Date:  2014-05-02       Impact factor: 15.828

8.  Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge.

Authors:  E B Eruslanov; K B Majorov; M O Orlova; V V Mischenko; T K Kondratieva; A S Apt; I V Lyadova
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

9.  Pectin-Derived Acidic Oligosaccharides Improve the Outcome of Pseudomonas aeruginosa Lung Infection in C57BL/6 Mice.

Authors:  Henry Bernard; Jean-Luc Desseyn; Frédéric Gottrand; Bernd Stahl; Nana Bartke; Marie-Odile Husson
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

10.  Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice.

Authors:  Anna B Sheremet; Naylia A Zigangirova; Egor S Zayakin; Sergei I Luyksaar; Lydia N Kapotina; Ludmila N Nesterenko; Natalie V Kobets; Alexander L Gintsburg
Journal:  Biomed Res Int       Date:  2018-09-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.